Grasp the latest information from Olin and understand the new trends in the industry.
On March 26, 2026, Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”, Stock Code: 688319) and Westlake University officially signed a cooperation agreement. Following multiple on-site inspections and in-
Recently, the China National Intellectual Property Administration issued the Notice on Determining the Demonstration Creation Objects for the Construction of a National Intellectual Property Powerhouse (2025-2027). Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”) was successfully selected as a “National Intellectual Property Demonstration Enterprise Creation Object” by virtue of its systematic layout and outstanding achievements in the comprehensive management of in
Recently, Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax” or the “Company”) successfully held the Kick-off Meeting & Investigator Training for Phase I Clinical Trials of Trivalent & Quadrivalent Influenza Virus Split Vaccines (MDCK Cells) in Xiangyun County, Xiangyun County, Dali Bai Autonomous Prefecture, Yunnan Province, marking new progress for the Company in the field of viral vaccines.
Feb 18th 2025, Olymvax and Griffith University of Australia held a signing ceremony in Chengdu for their collaboration on the GAS project and contract manufacturing of GAS vaccine.
Recently, SSE, SZSE and SEHK simultaneously announced the inclusion of more listed companies’ stocks into the Underlying Stock List of Northbound Trading Link, marking a further expansion of the interoperability range of stock market trading between Chinese Mainland and Hong Kong...
On the afternoon of February 13, 2023, Mr. Rob Donelly, Commercial Minister of the Commercial Counsellor’s Office of the Australian Embassy in China and General Manager of Austrade Greater China, Mr. Rhett Miller, Deputy Consul General of the Australian Consulate General in Chengdu and Trade and Investment Commissioner of the Austrade...